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ABSTRACT  
 
Background: Despite a 450% increase in UK alcohol-related liver disease mortality 
over the last 30 years, little evidence-based guidelines exist regarding recidivism 
prevention post-liver transplant for alcohol-related liver disease. 
 
Methods: A systematic review was conducted to identify demographic variables 
predictive of alcohol relapse and effective psychosocial interventions for alcohol-
related liver disease patients post-liver transplant. Medline; CINAHL; EMBASE; 
PsychInfo; Web of Science; Clinical Trials Register; Electronic Theses Online Service 
(ETHOS) were searched from inception to 2017.  
 
Results: Variables most significantly predictive of alcohol relapse post-transplant 
were: less than twelve (<12) months pre-liver transplant abstinence; presence of 
children; poor pre-liver transplant psychosomatic evaluation; non-compliance with 
post-liver transplant treatment plan; and active insurance policies. Structured 
management was the most effective psychosocial intervention in preventing 
alcohol relapse.  
 
Conclusion: Findings should be interpreted cautiously due to limited and poor 
quality evidence. Rigorously designed further research of the psychosocial 
interventions  targeting predictive demographic variables is recommended.  
 
Keywords: transplantation; systematic review; substance abuse; alcohol liver 
disease; post-liver transplantation. 
 
Summary box: 
 
 
 
 
 
‘What does this paper contribute to the wider global clinical 
community?’ 
 This paper provides an analysis of current research on 
psychosocial interventions for alcohol relapse in alcohol-related 
liver disease patients post-transplant; 
 Increases awareness to the wider global clinical community of 
the most predictive demographic variables for alcohol relapse 
in this patient group; 
 Details the most predictive alcohol usage demographic 
variables that effective psychosocial interventions could target 
when preventing alcohol relapse in alcohol-related liver disease 
patients post-transplant. 
  
 
 
INTRODUCTION  
 
Alcohol dependence treatment has been widely researched, ranging from brief 
interventions to pharmacotherapies accompanying withdrawal management e.g. 
acamprosate, naltrexone. A diverse array of psychosocial interventions are used in 
alcohol misuse treatment, with the most common being motivational interviewing 
and; cognitive behavioural therapy, including coping skills training, behavioural 
couple’s therapy and relapse prevention (Raistrick and Tober 2004). There has 
been significant progress in the development of these evidence-based psychosocial 
interventions, with the treatments considered essential to an alcohol misuse 
treatment programme and research supporting positive behavioural change 
(Jhanjee 2014). Furthermore, a number of self-help approaches are also available 
for alcohol dependence. For example, Alcoholics Anonymous (AA) focuses on 
shared experience and mutual support to recover from addiction, with an 
approximate membership of two million (Alcoholics Anonymous 2001). Whilst 
there is an evidence-base for alcohol dependence treatment as detailed above, 
minimal research has been conducted into alcohol-related liver disease post-
transplant.  
 
The 2011 National Institute for Health and Clinical Excellence (NICE) guidelines 
make recommendations for alcohol dependence, yet there are no specific 
guidelines in the treatment of alcohol-related liver disease (NICE 2011) This is 
concerning considering there has been a 450% increase in alcohol-related liver 
disease mortality in the United Kingdom (UK) over the last 30 years (British Liver 
Trust 2009). Furthermore, increased importance on tackling alcohol dependence is 
currently at the forefront of NHS England’s 2015 Mental Health Taskforce (NHS 
England 2015). Whilst systematic reviews have focused on alcohol dependence 
treatment (Pittler 2005; Miller 2011; Klimas et al. 2013), no systematic review was 
found on preventing alcohol relapse in alcohol-related liver disease patients post-
transplant to date.  
 
It remains uncertain whether the psychosocial interventions used for alcohol 
misuse will be as efficacious for liver transplant patients for alcohol-related liver 
disease (Kaner et al. 2009; Addolorato et al. 2013; Khan 2016). Although an 
argument could be that both populations have similar alcohol problems, the 
requirements for liver transplantation are stringent. The expectation for liver 
transplantation for alcohol-related liver disease is a documented alcohol abstinence 
of at least 6-months pre-transplant to predict long-term sobriety and ensure liver 
function recovery (Bird et al. 1990). However, this rule does not necessarily predict 
recidivism, with alcohol use post-transplant approaching 50% during the initial 5 
years (Fairbanks 2012).  
 
The overarching aim of this systematic review is to not only ascertain effective 
psychosocial interventions to prevent alcohol relapse in this population, but also 
identify specific demographic variables that such psychosocial interventions could 
target to ensure effective treatment. Both aspects of this review may assist nurses 
in developing an evidence-based post-liver transplant patient risk profile, as well as 
contribute to the specific post-liver transplant psychosocial interventions delivered 
by liver transplant nurses.  
  
 
METHOD 
 
Data sources, search strategy, and study selection 
 
Searches were conducted in January 2017 for published literature across four 
databases as well as searches for unpublished studies on three websites: Medline 
(1946-December 2017); CINAHL (1937-2017); EMBASE (1980-2017); PsychInfo 
(1806-2017); Web of Science; Clinical Trials Register; Electronic Theses Online 
Service (ETHOS). The key search terms were: liver transplant (MeSH), alcohol 
(MeSH), liver transplantation (free-text), alcohol$ (free-text).  Free-text was used to 
maximise search sensitivity. Search thoroughness was increased with a reference 
list search of the included studies. 
 
The primary author (IR) inspected all search citations, followed by relevant 
abstracts being identified independently and in parallel by the authors IR, IN, and 
MLW. IR undertook data extraction from included papers. At each stage, the entire 
review team reviewed the searches, screening of abstracts and full-texts, and 
results from data extraction. Review team discussion allowed for the resolving of 
any uncertainties. Author JS conducted an independent re-inspection of a random 
20% sample for reliability.  
 
Data extraction, study quality assessment, and analysis strategy  
 
This review adopted a narrative systematic analysis approach (Sin and Norman, 
2013). In accordance with the NICE Guidelines Manual (NICE 2012), data was 
extracted from all included studies for: 1) demographic variables predicting alcohol 
relapse; 2) psychosocial interventions. Data obtained included information about 
the sample, method, outcome and outcome measures. The included studies were 
critically appraised against the ‘Critical Appraisal Skills Programme (CASP)’ tool 
(Public Health Resource Unit 2012) and the relevant study reporting guidelines to 
determine risk of bias.  
 
RESULTS 
Overview of literature 
 
Figure 1 illustrates the search process and total number of included and excluded 
studies in this review. A total of 8564 studies were retrieved following the search, 
with 23 studies finally included in the review. Three authors were contacted (with 
one response) to retrieve unreported or unclear study information. Seven studies 
were excluded due to alcohol relapse not assessed as the study outcome (Abosh et 
al. 2000, Harper et al. 2010; Stilley et al. 2010; Telles-Correia 2011); study not 
completed (Weinrieb et al. 2001); and, intervention effectiveness not being 
investigated (Zibari et al. 1996; Georgiou et al. 2003).  
 
Overview of included studies  
 
Included study designs were case-control (n=11); cohort (n=10); qualitative (n=1); 
and randomised controlled trials (n=1). The primary outcome was alcohol use 
post-liver transplant. Data collection methods included questionnaires (n=7); 
record review (n=7); clinical interview (n=4); self-reports (n=2); objectives scales 
(n=2); psychosomatic evaluation (n=1). Included studies were from the USA 
(n=10), Europe (n=9), Canada (n=1), UK (n=1), Australia (n=1), and East Asia 
(n=1). Table 1 summarises the characteristics of the included studies.  
 
Quality of included studies 
 
Using the CASP quality assessment criteria, three studies were judged to be low 
risk of bias, 12 studies medium risk of bias, and 8 high risk of bias (see Table 1 for a 
quality rating for each included study).  
 
Overall, reporting of the included case-control and cohort studies conformed 
largely to the STROBE checklist (von Elm et al. 2008). However factors contributing 
to potential risks of bias include unjustified sample size, lack of validated outcome 
measures, and study withdrawals. The qualitative study by Newton (2006) met the 
majority of the COREQ criteria (Tong et al. 2007). However, the study failed to 
discuss reflexivity and data saturation. Furthermore, the randomised controlled 
trial conducted by Weinrieb et al (2011) did not fully meet CONSORT criteria 
(Schulz et al. 2010) nor fulfil checklist items such as appropriately describing the 
trial design, the method used to generate the random allocation sequence, or the 
type of randomisation.  
 
Demographic variables predicting alcohol relapse  
 
A total of 19 studies reported on demographic variables predicting alcohol relapse 
post-liver transplant. Two analyses were performed to ascertain these variables:  
 
1) Calculating the number of studies identifying a particular demographic variable 
as significantly predictive -  
 
Proportion of studies finding a statistically significant result with the demographic 
variable (%)   
= 
(Number of studies with significant results for the demographic variable/Total 
number of studies analysing the particular demographic variable) x100; 
 
2) Ranking the variables –  
 
Table 2 presents the most predictive demographic variable to least predictive of 
alcohol relapse post-transplant following the above calculation.  
 
The variables most significantly predictive of alcohol relapse post-transplant are: 
<12 months pre-liver transplant abstinence; presence of children; poor pre-liver 
transplant psychosomatic evaluation; non-compliance with post-liver transplant 
treatment plan; and, active insurance policies. However, the findings should be 
interpreted cautiously due to poor quality study designs.  
 
 
Psychosocial interventions to prevent alcohol relapse  
 
A total of four psychosocial intervention studies were included in this review (see 
Table 1): structured management (Bjornsson et al. 2005), clinical/medical 
management (Addolorato et al. 2013), substance abuse treatment using the 12-step 
programme (Rodrigue et al. 2013), and motivational enhancement (Weinrieb et al. 
2011). Alcohol use post-transplant is the primary dichotomous outcome in these 
studies. However no usable data is provided by Weinrieb et al (2011).  
 
All four interventions used an individual format. The motivational enhancement 
intervention had contact time between 4-7 sessions over 3-6 months (Weinrieb et 
al. 2011). The contact time is unclear in the remaining interventions (Bjornsson et 
al. 2005; Addolorato et al. 2013; Rodrigue et al. 2013). Overall, follow-up ranged 
from 3-55 months in the interventions structured management (Bjornsson et al. 
2005), substance abuse treatment (Rodrigue et al. 2013), and motivational 
enhancement (Weinrieb et al. 2011). The clinical/medical management 
intervention (Addolorato et al. 2013) was unclear regarding follow-up. Both the 
Addolorato et al (2013) and Bjornsson et al (2005) studies were found to have 
medium risk of bias, with a low risk of bias in Rodrigue et al (2013). Weinrieb et al 
(2011) had a high risk of bias due to a lack of detail regarding the randomisation 
process, unclear use of the intention-to-treat approach, and not using conventional 
alpha levels to predict sample size due to no similar previous papers having been 
conducted. As a result, the risk of committing a Type I error is increased. 
 
A suitable alpha level (i.e. significance level) at 5% was adopted by the three 
studies (Bjornsson et al. 2005; Addolorato et al. 2013; Rodrigue et al. 2013) to 
define the risk of a Type I error. The studies each have significant p-values – thus, 
the null hypothesis that the interventions have no effect on alcohol use post-
transplant can be rejected. Although positive odds ratios are found for alcohol use 
in these studies, statistical significance is not necessarily indicated. None of the 
three studies report confidence intervals, and the p-value does not indicate the 
actual size of the difference between the two groups i.e. ‘intervention’ and ‘no 
intervention’ group. Due to the missing confidence intervals, the uncertainty level 
around the odds ratio is unclear. Additionally, the controlling of all confounding 
factors cannot be ensured retrospectively. Thus, these three studies may have 
overestimated or underestimated the odds ratio. The three studies each 
appropriately use the independent t-test to compare two unrelated group means 
on the same continuous variable. However the three studies do not discuss the 
dependent variable’s approximate normal distribution for the independent variable 
groups, which would have aided assessment of study validity. Lastly, none of the 
four studies report a theoretical basis or the evidence-based origins of intervention 
development. 
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DISCUSSION  
 
A wide-range of demographic variables were found to predict alcohol relapse in 
alcohol-related liver disease patients post-transplant. Presence of children, poor 
pre-liver transplant psychosomatic evaluation, non-compliance with post-liver 
transplant treatment plan, active insurance policies, and <12 months pre-liver 
transplant abstinence were found to be more predictive of alcohol use post-
transplant than social circumstances, networks and personal relationships.  
 
Lower post-transplant alcohol use was found using three interventions: structured 
management (Bjornsson et al. 2005), clinical/medical management (Addolorato et 
al. 2013), substance abuse treatment using the 12-step programme (Rodrigue et al. 
2013). The structured management psychosocial intervention was found to be 
marginally more effective than the other interventions for alcohol-related liver 
disease patients (Bjornsson et al. 2005). 
 
 
Strengths and weaknesses of the study  
 
A lack of studies on demographic variables predictive of alcohol relapse has 
emerged from this review. Consequently, the ranking of these variables was 
tentative due to poor quality study designs. Thus, the wide range of variables were 
identified across studies but collectively no clearly significant variables were 
supports by the overall data.  
 
Overall, the intervention studies are largely incomparable due to poor descriptions 
and minimal information, suggesting insufficient evidence to report firm 
conclusions. Nevertheless, as this review reflects the best available evidence, and 
with no other accessible study matching the review criteria, it can be assumed 
these findings provide a foundation for future research. A limitation of this review 
is the substantial statistical and methodological heterogeneity between an already 
small number of intervention studies preventing a meta-analysis.  
 
 
CONCLUSION 
 
Alcohol-related liver disease appears to be a poorly understood illness, with wider 
literature predominantly focusing on other areas of alcohol misuse. Considering the 
seriousness of alcohol-related liver disease, the focus should be on the emotional, 
physical and financial impact the illness has on the patient and caregiver, as well as 
the increasing NHS costs to treat these patients.  
 
RELEVANCE TO CLINICAL PRACTICE  
 
The findings suggest that future research investigates further the predictive 
validity of the demographic variables most predictive of alcohol relapse. A point of 
consideration could be using the list of alcohol usage predictive demographic 
variables to inform the selection of transplant candidates in the future. This is due 
to the rising NHS costs to treat alcohol liver disease patients (British Liver Trust 
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2009); however, moral and ethical questions may be raised about treatment 
availability that are beyond the scope of this review.  
 
Three psychosocial intervention studies report desirable results in preventing 
alcohol relapse post-transplant: structured management (Bjornsson et al. 2005), 
clinical/medical management (Addolorato et al. 2013), substance abuse treatment 
(Rodrigue et al. 2013). It may be beneficial for such psychosocial interventions to 
focus on the demographic variables most predictive of alcohol relapse during 
intervention implementation to ensure effective treatment. Further research 
(particularly randomised controlled trials) is required to ascertain clinical 
effectiveness of such interventions. 
 
From this review, it is possible for nurses to explore and to develop an evidence-
based patient risk profile to inform the assessment and care management of post-
liver transplant patients. Furthermore, the risk variables identified in the review 
could contribute to the specific post-liver transplant psychosocial interventions 
delivered routinely by liver transplant nurses.  
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TABLES AND FIGURES 
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Study 
 
Sample 
Size 
 
 
 
 
Method 
-Format 
- Intervention contact time (if applicable) 
 
 
Control Group 
 
 
Follow Up 
 
Risk of 
Bias 
1. 
Addolorato et 
al (2013) 
Italy 
92 
 
-Clinical and medical management, involving counselling 
and pharmacological treatment.  
-Unclear contact time 
Seen by consultant 
psychiatrists addiction 
experts 
Unclear Medium 
2. Pfitzmann et 
al (2007) 
Germany 
290 
 
 
 
-Patient and family statements  
 
None 2-15 years Medium 
3. Weinrieb et 
al (2011) 
USA 
91 
 
-Randomised Controlled Trial - MET: feedback  and 
counselling style to motivate change. 
-4 to 7 sessions over 3 to 6 months  
TAU 3-12 months High 
4. DiMartini et 
al (2010) 
USA 
 
208 -ATLFB, caregiver questionnaire, clinic appointments and 
interviews by transplant psychiatrist 
None 3-6 months 
for 10 years 
Medium 
5. De Gottardi 
et al (2007) 
Switzerland 
and France 
387 
 
-HRAR, alcohol use post-LT. 
 
None  61.2±47.5 
months 
 
 
 
Medium 
6. DiMartini et 
al (2006) 
USA 
167 
 
 
-Alcohol use post-LT, carer questionnaire, psychiatrist 
interviews. 
None 5 years 
 
 
Low 
7. Kelly et al 
(2006) 
Australia 
100 
 
 
-Alcohol use post-LT.  
 
 
None 5.6 years Low 
13 
 
 
8. Perney et al 
(2005) 
France 
 
 
61 
 
 
-Alcohol use post-LT, pre and post-LT alcohol consumption 
questionnaire. 
 
None  6–126 
months 
 
 
Medium 
9. Osorio et al 
(1994) 
USA 
 
86 
 
 
 
-Alcohol use post-LT, pre and post-LT alcohol consumption 
questionnaire, interviews 
 
NALD 7-21 months 
  
Medium 
10. Bjornsson 
et al (2005) 
Sweden 
197 
 
-Structured management: evaluated by specialised 
consultant. Alcohol dependence treatment i.e. 12-step 
method. Post-LT: team social worker and LT coordinator 
appointments. 
-Unclear contact time. 
NALD 31 months 
 
Medium 
11. Miguet et al 
(2004) 
France 
51 
 
 
-Alcohol use post-LT, alcohol behaviour questionnaires.  
 
TAU 35.7 months 
 
 
High 
12. Jauhar et al 
(2004) 
USA 
111 -Alcohol use post-LT, laboratory tests, interviews None 44.1 ± 3.7 
months  
Medium 
13. Gish et al 
(2001) 
USA 
 
61 
 
-Alcohol use post-LT, pre and post-LT psychiatric 
assessment. 
 
 
None  6.9 years 
 
 
 
High 
14. Mackie et al 
(2001) 
UK 
133 
 
 
-Alcohol use post-LT, post-LT alcohol use questionnaire.  NALD 25 months 
 
 
High 
15. Burra et al 
(2000) 
Italy 
 
51 -Alcohol use post-LT, pre-LT alcohol use questionnaire, 
psychosocial interviews (pre and post-LT) 
None 3-12 months 
 
 
 
High 
14 
 
 
Table 1 Characteristics of included studiesa 
a LT: liver transplant; ALD: alcohol-related liver disease; ALC: alcohol liver cirrhosis; NALD: non-alcohol-related liver disease; TAU: treatment as 
usual; MET: Motivational Enhancement Therapy; SA: Substance Abuse; HRAR: High-Risk Alcohol dependence Relapse scale. 
 
16. Foster et al 
(1997) 
USA 
63 -Alcohol use post-LT, pre-LT psychosocial interviews None 49.3±21 
months 
 
High 
17. Gedaly et al 
(2008) 
USA 
147 -Alcohol use post-LT, liver function tests None  41.2 months  
 
Medium 
18. Newton 
(2006) 
USA 
76 
 
-Alcohol use post-LT None  None  
 
Medium 
19. Karim et al 
(2010) 
Canada 
80 
 
-Alcohol use post-LT, laboratory tests  None  Unclear  
 
Medium 
20. Egawa et al 
(2010) 
Japan 
195 -Alcohol use post-LT, patient and family interviews with 
psychiatrist 
None 3-4962 days  
 
High 
21. Rodrigue et 
al (2013) 
USA 
138 -SA treatment: 12-step program, attending weekly 
individual and group sessions 
-Unclear duration of treatment. 
No SA treatment 55 months  
 
Low 
22. Deruytter 
(2013) 
Belgium 
108 
 
 
-Alcohol use post-LT, pre and post-LT alcohol use 
questionnaire. 
None Mean 55 
months. 
 
 
High 
23. Hartl et al 
(2011) 
Germany 
226 -Alcohol use post-LT; post-LT psychiatric screening.  LT for diagnoses other 
than ALC 
31±23 
months  
 
 
Medium 
15 
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Table 2 Demographic variable ranking 
Demographic Variable (ranked from 
most-to-least predictive of alcohol 
relapse post-transplant) 
Proportion of included studies 
identifying the demographic 
variable as significantly predictive 
of alcohol relapse post-transplant 
(%) 
<12 months pre-liver transplant 
abstinence 
100 
Presence of children 100 
Poor pre-liver transplant 
psychosomatic evaluation 
100 
Non-compliant with post-liver 
transplant treatment plan 
100 
Active life insurance policy or other 
insurance policies at liver transplant 
100 
Mental illness 80 
Patient or family lacks insight into 
alcohol problem 
75 
≤6 months pre-liver transplant 
abstinence 
73 
Other substance use e.g. tobacco, illegal 
drugs 
70 
Pre-liver transplant alcohol 
rehabilitation (protective variable) 
67 
Divorced/separated/alone 62.5 
Family alcohol dependence history 57 
Positive support network (protective 
variable) 
50 
Pre-liver transplant alcohol misuse or 
dependence diagnosis 
50 
High HRAR score (≥3) 50 
Social issues e.g. unemployed, unstable 
housing 
43 
Age <40 years at liver transplant 40 
Age >50 years at liver transplant 40 
Married/significant other (protective 
variable) 
40 
Female gender 20 
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Figure 1 PRISMA flow diagram of the study selection process  
 
Demographic Variable Search: 
Records identified through database 
searching N=6340 
Psychosocial Intervention Search: 
Records identified through database 
searching N=1334 
 
Additional records identified 
through grey literature N=890 
Total references received N=8564 
Total abstracts screened N=783 
Total studies assessed for 
eligibility N=30 
Rejected at title N=7781 
Rejected at abstract N=753 
 
 
Excluded full studies N=7 
 
Studies included in this review 
N=23 
(Variable Studies N=19;  
Intervention Studies N=4) 
Additional records identified 
through reference lists of included 
studies N=0 
Treatment Programme to prevent 
alcohol relapse in liver transplant 
patients for alcohol-related liver 
disease 
